Literature DB >> 22664949

Reducing death from cancer: what will it take?

Margaret L Kripke1.   

Abstract

In spite of advances in cancer diagnosis and treatment, cancer remains a serious problem for most societies. It is unlikely that cancer can ever be eliminated entirely; therefore, we must continue to seek ways to reduce the incidence, morbidity, and mortality from this devastating disease. Although most cancer research is devoted to finding new treatments, there are many other obstacles to reducing death from cancer that will need to be addressed if significant progress is to be made. These include growth in the number of cancer cases owing to the increasing longevity of populations, unequal access to cancer care, the increasing number of cancer survivors, limited resources including human resources, and our inability to deal with preventable cancers. To address these challenges, we must make cancer a national and international priority. We must focus our attention on prevention, not just on treatment, including elimination of tobacco use and reduction in exposure to environmental carcinogens. Finally, we must improve the accessibility of cancer care and ensure that there will be new generations of oncologists, health-care providers, and biomedical researchers by investing in medical research and education.

Entities:  

Mesh:

Year:  2012        PMID: 22664949     DOI: 10.1007/s13277-012-0425-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  2 in total

1.  Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.

Authors:  Rebecca Siegel; Elizabeth Ward; Otis Brawley; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2011-06-17       Impact factor: 508.702

2.  Future supply and demand for oncologists : challenges to assuring access to oncology services.

Authors:  Clese Erikson; Edward Salsberg; Gaetano Forte; Suanna Bruinooge; Michael Goldstein
Journal:  J Oncol Pract       Date:  2007-03       Impact factor: 3.840

  2 in total
  3 in total

Review 1.  Approach to patients with unexplained multimorbidity with sensitivities.

Authors:  Stephen J Genuis; Marko G Tymchak
Journal:  Can Fam Physician       Date:  2014-06       Impact factor: 3.275

Review 2.  The war on cancer: are we winning?

Authors:  M J Duffy
Journal:  Tumour Biol       Date:  2013-04-09

3.  Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics.

Authors:  Meng Yang; Yun-Duo Liu; Yan-Ying Wang; Tian-Bo Liu; Ting-Ting Ge; Ge Lou
Journal:  Tumour Biol       Date:  2013-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.